Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605358 · ClinicalTrials.gov registry record · NA
Increasing Use of Mental Health Services
A NA study of Major Depression, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 161
- Enrollment target
- 1
- Study location
NCT00605358: Completed NA study of Major Depression, sponsored by Weill Medical College of Cornell University.
NCT00605358 is a NA study of Major Depression that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 161 participants, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00605358, a NA study of Major Depression, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 161 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the effectiveness of Open Door (previously known as the Treatment Initiation Program \[TIP\]), a brief psychosocial intervention to address the psychological barriers to care and improve the use of mental health services by depressed community elderly. The intervention is designed to help the older adult identify the barriers, problem-solve to find solutions and mobilize the motivation to seek help. Open Door was developed to work collaboratively with an older adult who is depressed to improve access and adherence to mental health treatment.
Primary Outcome
Engagement was defined as at least one visit with a mental health provider, due to the fact that in some treatment settings, the initial evaluation and the onset of treatment both took place in the first visit. The primary outcome, engagement, was counted if the participant had engaged in mental health treatment by EITHER 12 weeks OR 24 weeks, based on research suggesting that older adults may take up to 6 months to follow through on a referral. Therefore, while there is only a single primary
Conditions Studied
Interventions
- BEHAVIORAL Open Door intervention
Study Locations (1)
New York
- Weill Cornell Medical College - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2007-08 |
| Est. Completion | 2015-01 |
| Phase | NA |
What the finished NCT00605358 record still lists
NCT00605358 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 322-participant average among 28 other Major Depression trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Major Depression appearing as the primary indexed condition, and to 1 intervention - of which Open Door intervention is the first listed.
NCT00605358 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00605358 about?
NCT00605358 is a clinical study titled "Increasing Use of Mental Health Services". The purpose of this study is to test the effectiveness of Open Door (previously known as the Treatment Initiation Program \[TIP\]), a brief psychosocial intervention to address the psychological barriers to care and improve the use of mental health services by depressed community elderly. The interv...
What is the current status of trial NCT00605358?
This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2007-08. Estimated completion is 2015-01.
What conditions does trial NCT00605358 study?
This clinical trial studies the following conditions: Major Depression.
What interventions are being tested in trial NCT00605358?
The interventions under investigation include: Open Door intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00605358?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00605358 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Major Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00605358's enrollment target sits among peer trials
161 11th of 28 higher than 18 of 28 other Major Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Major Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Accelerated High-Dose tDCS for Depression
RECRUITING · NA
-
Person-Centered Versus Measurement-Based Care in Mental Health
COMPLETED · NA
-
Proactive Psychiatry Consultation for Patients With Cancer and Severe Mental Illness
COMPLETED · NA
-
The Brain on Whole Body Hyperthermia: A Neuroimaging Study
COMPLETED · NA
-
Motivational Interviews for Depression in Primary Care
COMPLETED · NA
-
The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness.
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia